Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer
Status:
Completed
Trial end date:
2021-02-15
Target enrollment:
Participant gender:
Summary
Evaluating efficacy and safety of bevacizumab when combined with chemotherapy (carboplatin
and Paclitaxel ) in treatment of patient with metastatic triple negative breast cancer